EDAP TMS (EDAP) Expected to Announce Quarterly Earnings on Thursday

Key Points

• Edap Tms is set to announce its Q2 2025 earnings on August 28, with analysts predicting a loss of ($0.18) per share and revenues of approximately $16.6 million.
• The company's stock price has declined by 7.1%, currently sitting at $1.3750, and has an average rating of "Hold" from analysts with a consensus price target of $8.50.
• Piper Sandler recently downgraded Edap Tms from an "overweight" to a "neutral" rating, reflecting a shift in market sentiment towards the stock.

EDAP TMS (NASDAQ:EDAP - Get Free Report) is expected to release its Q2 2025 results before the market opens on Thursday, August 28th. Analysts expect EDAP TMS to post earnings of ($0.18) per share and revenue of $16.5970 million for the quarter. Interested persons can find conference call details on the company's upcoming Q2 2025 earningreport page for the latest details on the call scheduled for Thursday, August 28, 2025 at 8:30 AM ET.

EDAP TMS Stock Performance

Shares of EDAP stock traded up $0.16 during mid-day trading on Tuesday, reaching $1.53. 130,614 shares of the company's stock traded hands, compared to its average volume of 67,918. EDAP TMS has a 12 month low of $1.21 and a 12 month high of $3.77. The firm has a 50 day moving average price of $1.49 and a two-hundred day moving average price of $1.85. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.21 and a current ratio of 1.74. The firm has a market capitalization of $57.21 million, a PE ratio of -2.47 and a beta of -0.09.

Wall Street Analyst Weigh In

EDAP has been the subject of several analyst reports. Piper Sandler lowered shares of EDAP TMS from an "overweight" rating to a "neutral" rating in a report on Thursday, May 15th. Wall Street Zen initiated coverage on shares of EDAP TMS in a report on Thursday, May 15th. They issued a "hold" rating for the company. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $8.50.

About EDAP TMS

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.